Dr. Brett King at Yale School of Medicine Department of Dermatology is accepting applications for a Postdoctoral Associate.
The Associate will participate as a sub-investigator in clinical trials, do clinical research, and spend time in a medical dermatology clinic. As a sub-investigator in clinical trials, the Associate will be an integral member of a clinical trials team, seeing patients and working closely with a trial coordinator and Dr. King. The Associate will conduct and publish the results of clinical research. This clinical experience will provide exposure to the care and management of patients with severe skin disease, including alopecia areata, vitiligo, atopic dermatitis, and other conditions.
The Associate must be a physician who has successfully completed internship year and who has an interest in medical dermatology. Dr. King's previous associate matched successfully in dermatology. The estimated start date is August 1, 2022.
About Dr. Brett King, MD, PhD: He is Associate Professor of Dermatology at the Yale School of Medicine. He has pioneered the use of JAK inhibitors in dermatology, in particular for alopecia areata, vitiligo, and atopic dermatitis, in addition to other disorders.
For additional information, please contact Dr. King directly by email at [email protected].
The Associate will participate as a sub-investigator in clinical trials, do clinical research, and spend time in a medical dermatology clinic. As a sub-investigator in clinical trials, the Associate will be an integral member of a clinical trials team, seeing patients and working closely with a trial coordinator and Dr. King. The Associate will conduct and publish the results of clinical research. This clinical experience will provide exposure to the care and management of patients with severe skin disease, including alopecia areata, vitiligo, atopic dermatitis, and other conditions.
The Associate must be a physician who has successfully completed internship year and who has an interest in medical dermatology. Dr. King's previous associate matched successfully in dermatology. The estimated start date is August 1, 2022.
About Dr. Brett King, MD, PhD: He is Associate Professor of Dermatology at the Yale School of Medicine. He has pioneered the use of JAK inhibitors in dermatology, in particular for alopecia areata, vitiligo, and atopic dermatitis, in addition to other disorders.
For additional information, please contact Dr. King directly by email at [email protected].
